159 related articles for article (PubMed ID: 23264361)
1. Low rates of treatment failure in children aged 2-59 months treated for severe pneumonia: a multisite pooled analysis.
Fox MP; Thea DM; Sadruddin S; Bari A; Bonawitz R; Hazir T; Bin Nisar Y; Qazi SA;
Clin Infect Dis; 2013 Apr; 56(7):978-87. PubMed ID: 23264361
[TBL] [Abstract][Full Text] [Related]
2. Outpatient treatment of children with severe pneumonia with oral amoxicillin in four countries: the MASS study.
Addo-Yobo E; Anh DD; El-Sayed HF; Fox LM; Fox MP; MacLeod W; Saha S; Tuan TA; Thea DM; Qazi S;
Trop Med Int Health; 2011 Aug; 16(8):995-1006. PubMed ID: 21545381
[TBL] [Abstract][Full Text] [Related]
3. One-arm safety intervention study on community case management of chest indrawing pneumonia in children in Nigeria - a study protocol.
Counihan H; Baba E; Oresanya O; Adesoro O; Hamzat Y; Marks S; Ward C; Gimba P; Qazi SA; Källander K
Glob Health Action; 2020 Dec; 13(1):1775368. PubMed ID: 32856569
[TBL] [Abstract][Full Text] [Related]
4. Clinical signs of possible serious infection and associated mortality among young infants presenting at first-level health facilities.
Nisar YB; Tshefu A; Longombe AL; Esamai F; Marete I; Ayede AI; Adejuyigbe EA; Wammanda RD; Qazi SA; Bahl R
PLoS One; 2021; 16(6):e0253110. PubMed ID: 34191832
[TBL] [Abstract][Full Text] [Related]
5. Predictors of treatment failure for non-severe childhood pneumonia in developing countries--systematic literature review and expert survey--the first step towards a community focused mHealth risk-assessment tool?
McCollum ED; King C; Hollowell R; Zhou J; Colbourn T; Nambiar B; Mukanga D; Burgess DC
BMC Pediatr; 2015 Jul; 15():74. PubMed ID: 26156710
[TBL] [Abstract][Full Text] [Related]
6. Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial.
Bari A; Sadruddin S; Khan A; Khan Iu; Khan A; Lehri IA; Macleod WB; Fox MP; Thea DM; Qazi SA
Lancet; 2011 Nov; 378(9805):1796-803. PubMed ID: 22078721
[TBL] [Abstract][Full Text] [Related]
7. Development of a prognostic risk score to aid antibiotic decision-making for children aged 2-59 months with World Health Organization fast breathing pneumonia in Malawi: An Innovative Treatments in Pneumonia (ITIP) secondary analysis.
McCollum ED; Brown SP; Nkwopara E; Mvalo T; May S; Ginsburg AS
PLoS One; 2019; 14(6):e0214583. PubMed ID: 31220085
[TBL] [Abstract][Full Text] [Related]
8. Innovative, enhanced community management of non-hypoxaemic chest-indrawing pneumonia in 2-59-month-old children: a cluster-randomised trial in Africa and Asia.
EMPIC Study Group
BMJ Glob Health; 2022 Jan; 7(1):. PubMed ID: 34987033
[TBL] [Abstract][Full Text] [Related]
9. Community case management of fast-breathing pneumonia with 3 days oral amoxicillin vs 5 days cotrimoxazole in children 2-59 months of age in rural Pakistan: A cluster randomized trial.
Ahmed S; Ariff S; Muhammed S; Rizvi A; Ahmed I; Soofi SB; Bhutta ZA
J Glob Health; 2022 Dec; 12():04097. PubMed ID: 36579494
[TBL] [Abstract][Full Text] [Related]
10. Non-treatment of children with community health worker-diagnosed fast-breathing pneumonia in rural Malawi: exploratory subanalysis of a prospective cohort study.
King C; Colbourn T; Mankhambo L; Beard J; Hay Burgess DC; Costello A; Izadnegahdar R; Lufesi N; Mwansambo C; Nambiar B; Johnson ES; Platt RW; Mukanga D; McCollum ED
BMJ Open; 2016 Nov; 6(11):e011636. PubMed ID: 27852705
[TBL] [Abstract][Full Text] [Related]
11. Etiology and Risk Factors Determining Poor Outcome of Severe Pneumonia in Under-Five Children.
Jakhar SK; Pandey M; Shah D; Ramachandran VG; Saha R; Gupta N; Gupta P
Indian J Pediatr; 2018 Jan; 85(1):20-24. PubMed ID: 29027126
[TBL] [Abstract][Full Text] [Related]
12. Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children.
Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Phiri M; Schmicker R; Hwang J; Ndamala CB; Phiri A; Lufesi N; May S
N Engl J Med; 2020 Jul; 383(1):13-23. PubMed ID: 32609979
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of hospital versus home based therapy with oral amoxicillin for severe pneumonia in children aged 3 - 59 months: The IndiaCLEN Severe Pneumonia Oral Therapy (ISPOT) Study.
Patel AB; Bang A; Singh M; Dhande L; Chelliah LR; Malik A; Khadse S;
BMC Pediatr; 2015 Nov; 15():186. PubMed ID: 26577943
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic therapy versus no antibiotic therapy for children aged two to 59 months with WHO-defined non-severe pneumonia and wheeze.
Lassi ZS; Kumar R; Das JK; Salam RA; Bhutta ZA
Cochrane Database Syst Rev; 2014 May; (5):CD009576. PubMed ID: 24859388
[TBL] [Abstract][Full Text] [Related]
15. Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol.
Ginsburg AS; May SJ; Nkwopara E; Ambler G; McCollum ED; Mvalo T; Phiri A; Lufesi N; Sadruddin S
BMC Infect Dis; 2018 Sep; 18(1):476. PubMed ID: 30241517
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2-59 Months in Pakistan: A Cluster-randomized Trial.
Sadruddin S; Khan IUH; Fox MP; Bari A; Khan A; Thea DM; Khan A; Khan I; Ahmad I; Qazi SA
Clin Infect Dis; 2019 Jul; 69(3):397-404. PubMed ID: 30596964
[TBL] [Abstract][Full Text] [Related]
17. Does 3-day course of oral amoxycillin benefit children of non-severe pneumonia with wheeze: a multicentric randomised controlled trial.
Awasthi S; Agarwal G; Kabra SK; Singhi S; Kulkarni M; More V; Niswade A; Pillai RM; Luke R; Srivastava NM; Suresh S; Verghese VP; Raghupathy P; Lodha R; Walter SD
PLoS One; 2008 Apr; 3(4):e1991. PubMed ID: 18431478
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis.
Mvalo T; Smith AG; Eckerle M; Hosseinipour MC; Kondowe D; Vaidya D; Liu Y; Corbett K; Nansongole D; Mtimaukanena TA; Lufesi N; McCollum ED
PLoS One; 2022; 17(12):e0278938. PubMed ID: 36516197
[TBL] [Abstract][Full Text] [Related]
19. Community case management of lower chest indrawing pneumonia with oral amoxicillin in children in Kenya.
Onono M; Abdi M; Mutai K; Asadhi E; Nyamai R; Okoth P; Qazi SA
Acta Paediatr; 2018 Dec; 107 Suppl 471():44-52. PubMed ID: 30570795
[TBL] [Abstract][Full Text] [Related]
20. Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial.
Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Ndamala CB; Schmicker R; Phiri A; Lufesi N; Izadnegahdar R; May S
JAMA Pediatr; 2019 Jan; 173(1):21-28. PubMed ID: 30419120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
